Inflammation meets metabolic disease: Gut feeling mediated by GLP-1
Chronic diseases such as obesity and diabetes, cardiovascular and inflammatory bowel diseases (IBD) share common features in their pathology. Metabolic disorders exhibit strong inflammatory underpinnings and vice versa, inflammation is associated with metabolic alterations. Next to cytokines and cel...
Main Authors: | Tamara eZietek, Eva eRath |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00154/full |
Similar Items
-
Models for Incretin Research: From the Intestine to the Whole Body
by: Tae Jung Oh
Published: (2016-03-01) -
Identification of lactic acid bacteria strains modulating incretin hormone secretion and gene expression in enteroendocrine cells
by: Harsh Panwar, et al.
Published: (2016-05-01) -
The Gut–Brain Axis and Its Role in Controlling Eating Behavior in Intestinal Inflammation
by: Gordon William Moran, et al.
Published: (2021-03-01) -
Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites
by: Annieke C G van Baar, et al.
Published: (2018-05-01) -
First GLP-1 analog liraglutide: the result of clinical trails on efficacy
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01)